RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding RenovoRx, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 9 | 14 | +5 |
| Shares | 244.3K | 363.6K | +119.3K (+48.8%) |
| Value | $552.2K | $473.5K | −$78.7K (−14.3%) |
New holders (5)
Institutions that held RenovoRx, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Charles Schwab Investment Management Inc | 49,232 | $62.0K | 0.00% |
| State Street Corp | 18,852 | $23.8K | 0.00% |
| BlackRock Inc. | 15,334 | $20.4K | 0.00% |
| Ground Swell Capital, LLC | 11,481 | $14.5K | 0.02% |
| JPMorgan Chase & Co | 9 | $11 | 0.00% |
Sold out (0)
Institutions that held RenovoRx, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.